Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Membrane toxicity. Advances in experimental medicine and biology

Identifieur interne : 003926 ( Main/Exploration ); précédent : 003925; suivant : 003927

Membrane toxicity. Advances in experimental medicine and biology

Auteurs :

Source :

RBID : ISTEX:737018A399AA5E0D25415569CF769DFEBC50C2E1

English descriptors


Url:
DOI: 10.1016/S0015-6264(78)80270-3


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Membrane toxicity. Advances in experimental medicine and biology</title>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:737018A399AA5E0D25415569CF769DFEBC50C2E1</idno>
<date when="1978" year="1978">1978</date>
<idno type="doi">10.1016/S0015-6264(78)80270-3</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-29497GNP-G/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001501</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001501</idno>
<idno type="wicri:Area/Istex/Curation">001501</idno>
<idno type="wicri:Area/Istex/Checkpoint">002678</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002678</idno>
<idno type="wicri:Area/Main/Merge">003A05</idno>
<idno type="wicri:Area/Main/Curation">003926</idno>
<idno type="wicri:Area/Main/Exploration">003926</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Membrane toxicity. Advances in experimental medicine and biology</title>
</analytic>
<monogr></monogr>
<series>
<title level="j">Food and Cosmetics Toxicology</title>
<title level="j" type="abbrev">FCTOX</title>
<idno type="ISSN">0015-6264</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1978">1978</date>
<biblScope unit="volume">16</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="487">487</biblScope>
</imprint>
<idno type="ISSN">0015-6264</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0015-6264</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acetylsalicyclic</term>
<term>Acetylsalicyclic acid</term>
<term>Acriflavinium</term>
<term>Acriflavinium chloride</term>
<term>Aetiological</term>
<term>Aetiological factors</term>
<term>Amino acids</term>
<term>Amobarbital</term>
<term>Animal data</term>
<term>Animal experiments</term>
<term>Animal species</term>
<term>Antifolate</term>
<term>Antifolate drugs</term>
<term>Appropriate synonyms</term>
<term>Aurothioglucose</term>
<term>Available data</term>
<term>Biochemical changes</term>
<term>Book reviews</term>
<term>Cancer epidemioand</term>
<term>Cancer epidemioiogy</term>
<term>Cancer epidemiology</term>
<term>Cancer epidemiology studies reports</term>
<term>Cancer registries</term>
<term>Cancer sites</term>
<term>Carbon tetrachloride</term>
<term>Carcinogenic</term>
<term>Carcinogenic risk</term>
<term>Carcinogenicity</term>
<term>Cell necrosis</term>
<term>Cellular responses</term>
<term>Chloroquine</term>
<term>Comprehensive directory</term>
<term>Considerable escalation</term>
<term>Cumulative index</term>
<term>Diphenylthiohydantoin</term>
<term>Dithranol</term>
<term>Environmental toxicity</term>
<term>Epidemioand</term>
<term>Epidemioiogy</term>
<term>Epidemiology</term>
<term>Ethicmamide</term>
<term>Excellent paper</term>
<term>Experimental medicine</term>
<term>Felicitous publication policy</term>
<term>Fifth sections</term>
<term>First section</term>
<term>First time</term>
<term>Future volumes</term>
<term>General reader</term>
<term>Glucose</term>
<term>Hazards vinyl chloride</term>
<term>Heavy metals</term>
<term>Hmso</term>
<term>Human data</term>
<term>Hycanthone</term>
<term>Hycanthone mesylate</term>
<term>Iarc</term>
<term>Iarc monographs</term>
<term>Immunology</term>
<term>Individual chemicals</term>
<term>Individual studies</term>
<term>International agency</term>
<term>International lyon</term>
<term>Intestinal</term>
<term>Intestinal transport</term>
<term>Iogy</term>
<term>Ionophores</term>
<term>Latest directory</term>
<term>Lectin</term>
<term>Limited value</term>
<term>Little attention</term>
<term>Little guidance</term>
<term>Macrophage</term>
<term>Main list</term>
<term>Major role</term>
<term>Malignant</term>
<term>Malignant cells</term>
<term>Membrane</term>
<term>Membrane conformation</term>
<term>Membrane damage</term>
<term>Membrane function</term>
<term>Membrane permeability</term>
<term>Membrane toxicity</term>
<term>Membrane transport</term>
<term>Mesylate</term>
<term>Metronidazole</term>
<term>Molecular probes</term>
<term>Monograph</term>
<term>Muir iarc</term>
<term>Niridazole</term>
<term>Nitroxoline</term>
<term>Ongoing</term>
<term>Ongoing research</term>
<term>Ouabain</term>
<term>Oxazepam</term>
<term>Oxymetholone</term>
<term>Pancreas</term>
<term>Pentobarbital</term>
<term>Pentobarbital sodium</term>
<term>Permeability</term>
<term>Phenacetin</term>
<term>Phenobarbital</term>
<term>Phenobarbital sodium</term>
<term>Phenylbutazone</term>
<term>Phenytoin</term>
<term>Plenum</term>
<term>Plenum publishing corp</term>
<term>Preventive measures</term>
<term>Previous monographs</term>
<term>Principal investigators</term>
<term>Pronetalol</term>
<term>Pronetalol hydrochloride</term>
<term>Prostate gland</term>
<term>Pyrazinamide</term>
<term>Pyrimelhu</term>
<term>Receptor</term>
<term>Receptor sites</term>
<term>Rifampicin</term>
<term>Riskbenefit</term>
<term>Riskbenefit evaluation</term>
<term>Second section</term>
<term>Shamoo</term>
<term>Specialized field</term>
<term>Specialized subjects</term>
<term>Spironolactone</term>
<term>Stilbene</term>
<term>Striking example</term>
<term>Study immunology</term>
<term>Such compounds</term>
<term>Third section</term>
<term>Thirteenth session</term>
<term>Toxic compounds</term>
<term>Toxic effects</term>
<term>Toxicity</term>
<term>Tumour</term>
<term>Tumour promoter</term>
<term>Unpublished projects</term>
<term>Uterus</term>
<term>Various aspects</term>
<term>Xenobiotics</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list></list>
<tree></tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003926 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003926 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:737018A399AA5E0D25415569CF769DFEBC50C2E1
   |texte=   Membrane toxicity. Advances in experimental medicine and biology
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021